Steris (STE) Net Income Growth (3y) (2021 - 2025)
Steris (STE) Net Income Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 2.38% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 60.12% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 280.49% |
| 10 | Steris | 21.41 Bn | 20.97 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -26.17% |
| Dec 31, 2024 | -26.01% |
| Sep 30, 2024 | -26.05% |
| Jun 30, 2024 | 31.15% |
| Mar 31, 2024 | -55.76% |
| Dec 31, 2023 | -27.38% |
| Sep 30, 2023 | -26.87% |
| Jun 30, 2023 | -27.57% |
| Mar 31, 2023 | -68.21% |
| Dec 31, 2022 | -27.51% |
| Sep 30, 2022 | -87.73% |
| Jun 30, 2022 | -27.73% |
| Mar 31, 2022 | -4.80% |
| Dec 31, 2021 | 43.50% |
| Sep 30, 2021 | -3.51% |
| Jun 30, 2021 | -32.22% |
| Mar 31, 2021 | -32.24% |